APA (7th ed.) Citation

Tard, C., Bouhour, F., Michaud, M., Beltran, S., Fournier, M., Demurger, F., . . . Spinazzi, M. (2024). Real‐life effectiveness 1 year after switching to avalglucosidase alfa in late‐onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study. European Journal of Neurology, 31(7), 1. https://doi.org/10.1111/ene.16292

Chicago Style (17th ed.) Citation

Tard, Céline, et al. "Real‐life Effectiveness 1 Year After Switching to Avalglucosidase Alfa in Late‐onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study." European Journal of Neurology 31, no. 7 (2024): 1. https://doi.org/10.1111/ene.16292.

MLA (9th ed.) Citation

Tard, Céline, et al. "Real‐life Effectiveness 1 Year After Switching to Avalglucosidase Alfa in Late‐onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study." European Journal of Neurology, vol. 31, no. 7, 2024, p. 1, https://doi.org/10.1111/ene.16292.